Twelve-week outcomes from an investigation of high-dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence
- PMID: 15008689
- DOI: 10.1037/0893-164X.18.1.78
Twelve-week outcomes from an investigation of high-dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence
Abstract
This study reports findings from an investigation of the efficacy of high-dose nicotine patch (NP) therapy for heavy smokers with a past history of alcohol dependence. One hundred thirty participants were randomly assigned to 42 mg or 21 mg of transdermal nicotine for 4 weeks, followed by an 8-week dose titration. Follow-up assessments were conducted at 4 and 12 weeks. Differences between dose conditions were nonsignificant, although unexpectedly, outcomes favored participants in the 21-mg NP condition. Nicotine abstinence at follow-up was related to longer length of alcohol abstinence at time of enrollment. Future research should investigate ways to improve smoking quit rates in this population, including more frequent counseling sessions and/or other pharmacotherapies. These investigations should focus primarily on smokers in early alcohol recovery.
Similar articles
-
High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes.J Subst Abuse Treat. 2006 Apr;30(3):213-7. doi: 10.1016/j.jsat.2006.01.001. J Subst Abuse Treat. 2006. PMID: 16616165 Clinical Trial.
-
Efficacy of nicotine patch in smokers with a history of alcoholism.Alcohol Clin Exp Res. 2003 Jun;27(6):946-54. doi: 10.1097/01.ALC.0000071742.86555.4D. Alcohol Clin Exp Res. 2003. PMID: 12824815 Clinical Trial.
-
A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.Arch Intern Med. 2006 Mar 27;166(6):667-74. doi: 10.1001/archinte.166.6.667. Arch Intern Med. 2006. PMID: 16567607 Clinical Trial.
-
Do smokers with alcohol problems have more difficulty quitting?Drug Alcohol Depend. 2006 Apr 28;82(2):91-102. doi: 10.1016/j.drugalcdep.2005.08.018. Epub 2005 Sep 26. Drug Alcohol Depend. 2006. PMID: 16188401 Review.
-
Pharmacotherapy for alcoholic smokers.Alcohol Clin Exp Res. 2002 Dec;26(12):1939-41. doi: 10.1097/01.ALC.0000041002.32115.8E. Alcohol Clin Exp Res. 2002. PMID: 12500128 Review. No abstract available.
Cited by
-
A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.Arch Gen Psychiatry. 2009 Nov;66(11):1253-62. doi: 10.1001/archgenpsychiatry.2009.142. Arch Gen Psychiatry. 2009. PMID: 19884613 Free PMC article. Clinical Trial.
-
High dose transdermal nicotine for fast metabolizers of nicotine: a proof of concept placebo-controlled trial.Nicotine Tob Res. 2013 Feb;15(2):348-54. doi: 10.1093/ntr/nts129. Epub 2012 May 15. Nicotine Tob Res. 2013. PMID: 22589423 Free PMC article. Clinical Trial.
-
Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders.Cochrane Database Syst Rev. 2016 Nov 23;11(11):CD010274. doi: 10.1002/14651858.CD010274.pub2. Cochrane Database Syst Rev. 2016. PMID: 27878808 Free PMC article.
-
A tobacco reconceptualization in psychiatry: toward the development of tobacco-free psychiatric facilities.Am J Addict. 2010 Jul-Aug;19(4):293-311. doi: 10.1111/j.1521-0391.2010.00051.x. Am J Addict. 2010. PMID: 20653636 Free PMC article. Review.
-
Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review.Alcohol Alcohol. 2007 May-Jun;42(3):196-206. doi: 10.1093/alcalc/agm022. Alcohol Alcohol. 2007. PMID: 17526629 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous